
### [NCIT:C37204](http://purl.obolibrary.org/obo/NCIT_C37204)
**Label:** Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene

**Subclasses:** [NCIT:C37205](http://purl.obolibrary.org/obo/NCIT_C37205) (Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene), [NCIT:C37206](http://purl.obolibrary.org/obo/NCIT_C37206) (Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene), 

**Class expressions from DL-Learner:**

- [NCIT:C97146](http://purl.obolibrary.org/obo/NCIT_C97146) (Unmutated Immunoglobulin Heavy Chain Variable Region Gene) 58.33%
- Thing 52.49%
- [NCIT:C45576](http://purl.obolibrary.org/obo/NCIT_C45576) (Mutation Abnormality) 43.69%
- [NCIT:C17666](http://purl.obolibrary.org/obo/NCIT_C17666) (Germline Mutation) 43.69%
- [NCIT:C17666](http://purl.obolibrary.org/obo/NCIT_C17666) (Germline Mutation) and (not ([NCIT:C39101](http://purl.obolibrary.org/obo/NCIT_C39101) (Human Cytomegalovirus Infection Pathway))) 43.69%
- [NCIT:C17666](http://purl.obolibrary.org/obo/NCIT_C17666) (Germline Mutation) and (not ([NCIT:C39094](http://purl.obolibrary.org/obo/NCIT_C39094) (Inhibition of Cellular Proliferation by Gleevec Pathway))) 43.69%
- [NCIT:C17666](http://purl.obolibrary.org/obo/NCIT_C17666) (Germline Mutation) and (not ([NCIT:C39092](http://purl.obolibrary.org/obo/NCIT_C39092) (Growth Hormone Signaling Pathway))) 43.69%
- [NCIT:C17666](http://purl.obolibrary.org/obo/NCIT_C17666) (Germline Mutation) and (not ([NCIT:C39091](http://purl.obolibrary.org/obo/NCIT_C39091) (Corticosteroid Cardioprotection Pathway))) 43.69%
- [NCIT:C17666](http://purl.obolibrary.org/obo/NCIT_C17666) (Germline Mutation) and (not ([NCIT:C39088](http://purl.obolibrary.org/obo/NCIT_C39088) (G2/M Checkpoint Pathway))) 43.69%
- [NCIT:C17666](http://purl.obolibrary.org/obo/NCIT_C17666) (Germline Mutation) and (not ([NCIT:C39079](http://purl.obolibrary.org/obo/NCIT_C39079) (Fc Epsilon Receptor I Signaling Pathway BioCarta))) 43.69%
- [NCIT:C17666](http://purl.obolibrary.org/obo/NCIT_C17666) (Germline Mutation) and (not ([NCIT:C39072](http://purl.obolibrary.org/obo/NCIT_C39072) (Erk1/Erk2 MAPK Signaling Pathway))) 43.69%
- [NCIT:C17666](http://purl.obolibrary.org/obo/NCIT_C17666) (Germline Mutation) and (not ([NCIT:C39071](http://purl.obolibrary.org/obo/NCIT_C39071) (Neuronal Survival Pathway))) 43.69%
- [NCIT:C17666](http://purl.obolibrary.org/obo/NCIT_C17666) (Germline Mutation) and (not ([NCIT:C39069](http://purl.obolibrary.org/obo/NCIT_C39069) (ErbB3 Receptor Recycling Pathway))) 43.69%
- [NCIT:C17666](http://purl.obolibrary.org/obo/NCIT_C17666) (Germline Mutation) and (not ([NCIT:C39067](http://purl.obolibrary.org/obo/NCIT_C39067) (EPO Signaling Pathway))) 43.69%
- [NCIT:C17666](http://purl.obolibrary.org/obo/NCIT_C17666) (Germline Mutation) and (not ([NCIT:C39066](http://purl.obolibrary.org/obo/NCIT_C39066) (Erythropoietin Neuroprotection Pathway))) 43.69%


